지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
이용수
등록된 정보가 없습니다.
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
Hepatitis C Virus Associated Hepatocellular Carcinoma Risk
Asian Pacific journal of cancer prevention : APJCP
2015 .01
Long-term surgical outcomes of liver resection for hepatocellular carcinoma in patients with hepatitis B virus and hepatitis C virus co-infection: A multicenter observational study
Annals of Hepato-Biliary-Pancreatic Surgery
2021 .12
Risk factors for poor survival after recurrence of hepatocellular carcinoma after liver transplantation
Annals of Hepato-Biliary-Pancreatic Surgery
2021 .12
Risk factors for poor survival after recurrence of hepatocellular carcinoma after liver transplantation
대한임상종양학회 학술대회지
2022 .02
Risk factors for poor survival after recurrence of hepatocellular carcinoma after liver transplantation
Annals of Surgical Treatment and Research
2021 .07
Expanding Indications for Liver Transplant: Tumor and Patient Factors
Gut and Liver
2021 .01
Hepatectomy outcomes in patients with hepatitis C virus-related hepatocellular carcinoma with or without cirrhosis
Annals of Hepato-Biliary-Pancreatic Surgery
2021 .12
Can hepatocellular carcinoma recurrence be prevented after liver transplantation?
Clinical and Molecular Hepatology
2021 .10
Circulating tumour cells and their impact on the management of the liver transplant patient with hepatocellular carcinoma
Annals of Hepato-Biliary-Pancreatic Surgery
2022 .12
Correspondence on Editorial regarding “Impact of nationwide hepatocellular carcinoma surveillance on the prognosis in patients with chronic liver disease”
Clinical and Molecular Hepatology
2023 .01
How long should physicians follow up with patients after curative treatment for hepatocellular carcinoma?
Clinical and Molecular Hepatology
2020 .01
Direct-Acting Antiviral Therapy and Risk of Hepatocellular Carcinoma Recurrence in Patients with Chronic Hepatitis C
Gut and Liver
2021 .01
Clinical features of recurrence after hepatic resection for early-stage hepatocellular carcinoma and long-term survival outcomes of patients with recurrence: A multi-institutional analysis
Annals of Hepato-Biliary-Pancreatic Surgery
2022 .12
Long-term outcomes of liver resection for multiple hepatocellular carcinomas: Single-institution experience with 187 patients
Annals of Hepato-Biliary-Pancreatic Surgery
2020 .11
Long-term oncologic outcomes of liver resection for hepatocellular carcinoma in adolescents and young adults: A multicenter study from a hepatitis B virus-endemic area
Annals of Hepato-Biliary-Pancreatic Surgery
2021 .12
Systemic therapy in advanced hepatocellular carcinoma
Clinical and Molecular Hepatology
2023 .04
Risk of hepatocellular carcinoma in untreated patients with chronic hepatitis B: Independent of HBeAg status?
Clinical and Molecular Hepatology
2021 .01
Liver resection in elderly hepatocellular carcinoma patients (≥ 75 years) is safe
Annals of Hepato-Biliary-Pancreatic Surgery
2021 .12
The prognosis in cases of hepatocellular carcinoma after hepatectomy: young patients versus older patients
Annals of Hepato-Biliary-Pancreatic Surgery
2015 .11
Realization of improved outcomes following liver resection in hepatocellular carcinoma patients 75 years of age and older
Annals of Hepato-Biliary-Pancreatic Surgery
2022 .12
0